Literature DB >> 12521851

Histological chorioamnionitis in relation to clinical presentation at 14-40 weeks of gestation.

N J Sebire1, R D Goldin, L Regan.   

Abstract

This study examines the prevalence of histological inflammation of the fetal membranes according to gestational age and mode of clinical presentation in a series of 179 consecutive placentas evaluated in a single centre. The frequency of histological inflammation between clinical groups was compared and relation between the prevalence of inflammation and gestational age examined using regression analysis. One hundred and seventy-nine placentas were examined. Histological inflammation was present in 65 (38%) cases including 37/52 (71%) pregnancies presenting with spontaneous preterm labour and delivery (PTL), 23/36 (64%) with preterm prelabour rupture of membranes (PPROM), 1/20 (5%) with vaginal bleeding but no contractions (PVB), 1/13 (8%) with intrauterine death but no labour (IUD), 1/28 (4%) with iatrogenic delivery, 0/4 with termination of pregnancy and 2/20 (10%) delivering spontaneously at term. The prevalence of histological inflammation was significantly higher in those with PTL or PPROM compared to the other groups (P<0.0001). The frequency of histological inflammation was associated with gestational age (F=57.2, P<0.0001, R=0.91), with a peak prevalence (>90%) at 20-24 weeks' gestation.

Entities:  

Year:  2001        PMID: 12521851     DOI: 10.1080/01443610120046323

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  9 in total

1.  Frequency and clinical significance of placental histological lesions in an unselected population at or near term.

Authors:  Sangeeta Pathak; Christoph C Lees; Gerald Hackett; Flora Jessop; Neil J Sebire
Journal:  Virchows Arch       Date:  2011-10-27       Impact factor: 4.064

2.  Patterns of placental pathology in preterm premature rupture of membranes.

Authors:  J Armstrong-Wells; M D Post; M Donnelly; M J Manco-Johnson; B M Fisher; V D Winn
Journal:  J Dev Orig Health Dis       Date:  2013-06       Impact factor: 2.401

3.  Chorioamnionitis-induced changes of fetal extramedullar hematopoiesis in the second trimester of gestation. Is diagnosis from fetal autopsy possible?

Authors:  Cora Pfisterer; Renaldo Faber; Lars-Christian Horn
Journal:  Virchows Arch       Date:  2004-12-04       Impact factor: 4.064

4.  Prevalence and risk factors of chorioamnionitis in Dhaka, Bangladesh.

Authors:  G J Chan; M Silverman; M Zaman; A Murillo-Chaves; A Mahmud; A H Baqui; T K Boyd
Journal:  J Perinatol       Date:  2016-09-15       Impact factor: 2.521

5.  Early postnatal skin colour changes in term newborns with subclinical histological chorioamnionitis.

Authors:  Claudio De Felice; Paola Vacca; Antonio Del Vecchio; Mario Criscuolo; Antonia Lozupone; Giuseppe Latini
Journal:  Eur J Pediatr       Date:  2004-07-06       Impact factor: 3.183

6.  The frequency and type of placental histologic lesions in term pregnancies with normal outcome.

Authors:  Roberto Romero; Yeon Mee Kim; Percy Pacora; Chong Jai Kim; Neta Benshalom-Tirosh; Sunil Jaiman; Gaurav Bhatti; Jung-Sun Kim; Faisal Qureshi; Suzanne M Jacques; Eun Jung Jung; Lami Yeo; Bogdan Panaitescu; Eli Maymon; Sonia S Hassan; Chaur-Dong Hsu; Offer Erez
Journal:  J Perinat Med       Date:  2018-08-28       Impact factor: 1.901

7.  Funisitis is associated with adverse neonatal outcome in low-risk unselected deliveries at or near term.

Authors:  F A Jessop; C C Lees; S Pathak; C E Hook; N J Sebire
Journal:  Virchows Arch       Date:  2016-02-11       Impact factor: 4.064

8.  Bacterial communities found in placental tissues are associated with severe chorioamnionitis and adverse birth outcomes.

Authors:  Ronan M Doyle; Kathryn Harris; Steve Kamiza; Ulla Harjunmaa; Ulla Ashorn; Minyanga Nkhoma; Kathryn G Dewey; Kenneth Maleta; Per Ashorn; Nigel Klein
Journal:  PLoS One       Date:  2017-07-12       Impact factor: 3.240

9.  Neonatal respiratory morbidity following exposure to chorioamnionitis.

Authors:  Amy Metcalfe; Sarka Lisonkova; Yasser Sabr; Amelie Stritzke; K S Joseph
Journal:  BMC Pediatr       Date:  2017-05-17       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.